0 Ratings

ID

45620

Description

Principal Investigator: Jeffrey P. MacKeigan, PhD, Van Andel Institute, Grand Rapids, MI, USA MeSH: Tuberous Sclerosis https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001357 In this study, we characterized the genomic landscape of tuberous sclerosis complex (TSC), a rare genetic disease causing multisystem growth of benign tumors and other hamartomatous lesions. We analyzed 127 human tissues, including 111 TSC-associated samples and 16 non-TSC negative controls, using multiple genomic platforms including whole exome sequencing, targeted sequencing of known disease-causative loci (*TSC1* and *TSC2*), mRNA sequencing, high-density SNP arrays, and DNA methylation arrays.

Link

dbGaP study = phs001357

Keywords

  1. 27.02.23 27.02.23 - Simon Heim
Copyright Holder

Jeffrey P. MacKeigan, PhD, Van Andel Institute, Grand Rapids, MI, USA

Uploaded on

27. Februar 2023

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    dbGaP phs001357 The Genomic Landscape of Tuberous Sclerosis Complex (TSC)

    Eligibility Criteria

    Inclusion and exclusion criteria
    Description

    Inclusion and exclusion criteria

    Alias
    UMLS CUI [1,1]
    C1512693
    UMLS CUI [1,2]
    C0680251
    Samples from TSC patients or non-TSC organ donors were acquired from the NIH NeuroBioBank's Brain and Tissue Repository at the University of Maryland, Houston McGovern Medical School at the University of Texas, Cincinnati Children's Hospital Medical Center, New York University School of Medicine, and Helen DeVos Children's Hospital. Samples were reviewed by a certified clinical pathologist to confirm tissue type and assess integrity, whenever possible (samples with inconsistent, unlikely to be consistent, or unclear diagnoses were excluded from the study). Tissues that failed to produce a sufficient amount of high-uality DNA and/or RNA for sequencing or other array-based analyses were excluded. Samples were also excluded if they failed to produce usable data on two of three DNA platforms (WES, SNP array, targeted TSC sequencing), with the exception of one non-tumor tissue sample in which the germline mutation was identified in the completed platform (eliminating the need for the additional platforms to be completed).
    Description

    Samples from TSC patients or non-TSC organ donors were acquired from the NIH NeuroBioBank's Brain and Tissue Repository at the University of Maryland, Houston McGovern Medical School at the University of Texas, Cincinnati Children's Hospital Medical Center, New York University School of Medicine, and Helen DeVos Children's Hospital. Samples were reviewed by a certified clinical pathologist to confirm tissue type and assess integrity, whenever possible (samples with inconsistent, unlikely to be consistent, or unclear diagnoses were excluded from the study). Tissues that failed to produce a sufficient amount of high-uality DNA and/or RNA for sequencing or other array-based analyses were excluded. Samples were also excluded if they failed to produce usable data on two of three DNA platforms (WES, SNP array, targeted TSC sequencing), with the exception of one non-tumor tissue sample in which the germline mutation was identified in the completed platform (eliminating the need for the additional platforms to be completed).

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0370003
    UMLS CUI [1,2]
    C0041341
    UMLS CUI [1,3]
    C0029206
    UMLS CUI [1,4]
    C0027468
    UMLS CUI [1,5]
    C0040278
    UMLS CUI [1,6]
    C3847505
    UMLS CUI [1,7]
    C3846158
    UMLS CUI [1,8]
    C0334901
    UMLS CUI [1,9]
    C1709940
    UMLS CUI [1,10]
    C0521091
    UMLS CUI [1,11]
    C2713035
    UMLS CUI [1,12]
    C0518718
    UMLS CUI [1,13]
    C0680251
    UMLS CUI [1,14]
    C1299582
    UMLS CUI [1,15]
    C4708858
    UMLS CUI [1,16]
    C0012854
    UMLS CUI [1,17]
    C0035668
    UMLS CUI [1,18]
    C1547867
    UMLS CUI [1,19]
    C1561491
    UMLS CUI [1,20]
    C3640077
    UMLS CUI [1,21]
    C3897601
    UMLS CUI [1,22]
    C1705847
    UMLS CUI [1,23]
    C5237809
    UMLS CUI [1,24]
    C0206530
    UMLS CUI [1,25]
    C2964215

    Similar models

    Eligibility Criteria

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Inclusion and exclusion criteria
    C1512693 (UMLS CUI [1,1])
    C0680251 (UMLS CUI [1,2])
    Samples from TSC patients or non-TSC organ donors were acquired from the NIH NeuroBioBank's Brain and Tissue Repository at the University of Maryland, Houston McGovern Medical School at the University of Texas, Cincinnati Children's Hospital Medical Center, New York University School of Medicine, and Helen DeVos Children's Hospital. Samples were reviewed by a certified clinical pathologist to confirm tissue type and assess integrity, whenever possible (samples with inconsistent, unlikely to be consistent, or unclear diagnoses were excluded from the study). Tissues that failed to produce a sufficient amount of high-uality DNA and/or RNA for sequencing or other array-based analyses were excluded. Samples were also excluded if they failed to produce usable data on two of three DNA platforms (WES, SNP array, targeted TSC sequencing), with the exception of one non-tumor tissue sample in which the germline mutation was identified in the completed platform (eliminating the need for the additional platforms to be completed).
    Item
    Samples from TSC patients or non-TSC organ donors were acquired from the NIH NeuroBioBank's Brain and Tissue Repository at the University of Maryland, Houston McGovern Medical School at the University of Texas, Cincinnati Children's Hospital Medical Center, New York University School of Medicine, and Helen DeVos Children's Hospital. Samples were reviewed by a certified clinical pathologist to confirm tissue type and assess integrity, whenever possible (samples with inconsistent, unlikely to be consistent, or unclear diagnoses were excluded from the study). Tissues that failed to produce a sufficient amount of high-uality DNA and/or RNA for sequencing or other array-based analyses were excluded. Samples were also excluded if they failed to produce usable data on two of three DNA platforms (WES, SNP array, targeted TSC sequencing), with the exception of one non-tumor tissue sample in which the germline mutation was identified in the completed platform (eliminating the need for the additional platforms to be completed).
    boolean
    C0370003 (UMLS CUI [1,1])
    C0041341 (UMLS CUI [1,2])
    C0029206 (UMLS CUI [1,3])
    C0027468 (UMLS CUI [1,4])
    C0040278 (UMLS CUI [1,5])
    C3847505 (UMLS CUI [1,6])
    C3846158 (UMLS CUI [1,7])
    C0334901 (UMLS CUI [1,8])
    C1709940 (UMLS CUI [1,9])
    C0521091 (UMLS CUI [1,10])
    C2713035 (UMLS CUI [1,11])
    C0518718 (UMLS CUI [1,12])
    C0680251 (UMLS CUI [1,13])
    C1299582 (UMLS CUI [1,14])
    C4708858 (UMLS CUI [1,15])
    C0012854 (UMLS CUI [1,16])
    C0035668 (UMLS CUI [1,17])
    C1547867 (UMLS CUI [1,18])
    C1561491 (UMLS CUI [1,19])
    C3640077 (UMLS CUI [1,20])
    C3897601 (UMLS CUI [1,21])
    C1705847 (UMLS CUI [1,22])
    C5237809 (UMLS CUI [1,23])
    C0206530 (UMLS CUI [1,24])
    C2964215 (UMLS CUI [1,25])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial